|
|||||
|
|
Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan |
|
| Authors: | Jason C. Hsu Ching‐Lan Cheng Dennis Ross‐Degnan Anita K. Wagner Fang Zhang Yea‐Huei Kao Yang Li‐Ling Liu Hsueh‐Yung Tai Ke‐Hsin Chen Po‐Wen Yang Christine Y. Lu |
| Affiliation: | 1. School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan;2. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA;3. Division of Drug, Food and Drug Administration, Ministry of Health and Welfare, Taipei, Taiwan |
| Abstract: | |
| Keywords: | type 2 diabetes thiazolidinedione safety warning risk management plan Taiwan pharmacoepidemiology |